Literature DB >> 4112017

Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type).

M Adachi, J Torii, L Schneck, B W Volk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4112017     DOI： 10.1007/bf00687899

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  17 in total

1.  MITOCHONDRIAL MORPHOGENESIS.

Authors:  O A SCHJEIDE; R G MCCANDLESS; R J MUNN
Journal:  Nature       Date:  1964-07-11       Impact factor: 49.962

2.  A histological and chemical study of three cases of diffuse cerebral sclerosis.

Authors:  W BLACKWOOD; J N CUMINGS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-02       Impact factor: 10.154

3.  Fine structure of spongy degeneration of the central nervous system (van Bogaert and Bertrand type).

Authors:  M Adachi; B J Wallace; L Schneck; B W Volk
Journal:  J Neuropathol Exp Neurol       Date:  1966-10       Impact factor: 3.685

Review 4.  Genetics and phenogenetics of mitochondria.

Authors:  R P Wagner
Journal:  Science       Date:  1969-03-07       Impact factor: 47.728

Review 5.  The mitochondrion.

Authors:  D F Tapley; D V Kimberg; J L Buchanan
Journal:  N Engl J Med       Date:  1967-05-18       Impact factor: 91.245

6.  Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease). An ultrastructural study.

Authors:  P Gambetti; W J Mellman; N K Gonatas
Journal:  Acta Neuropathol       Date:  1969-01-31       Impact factor: 17.088

7.  Mitochondrial research today.

Authors:  D O Hall; J M Palmer
Journal:  Nature       Date:  1969-02-22       Impact factor: 49.962

8.  Spongy degeneration of the brain. A chemical study of two cases including isolation and characterization of myelin.

Authors:  S Kamoshita; I Rapin; K Suzuki; K Suzuki
Journal:  Neurology       Date:  1968-10       Impact factor: 9.910

9.  Correlation of mitochondrial structure and function.

Authors:  D E Green; J F Perdue
Journal:  Ann N Y Acad Sci       Date:  1966-07-14       Impact factor: 5.691

10.  HELICAL FILAMENTS IN ASTROCYTIC MITOCHONDRIA OF THE CORPUS STRIATUM IN THE RAT.

Authors:  E MUGNAINI
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539
View more
  11 in total

Review 1.  Biochemistry and molecular biology of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Spongy degeneration of the central nervous system in kittens.

Authors:  D F Kelly; C J Gaskell
Journal:  Acta Neuropathol       Date:  1976-06-15       Impact factor: 17.088

3.  N-acetylaspartic acid impairs enzymatic antioxidant defenses and enhances hydrogen peroxide concentration in rat brain.

Authors:  Carolina Didonet Pederzolli; Caroline Paula Mescka; Alessandra Selinger Magnusson; Kátia Bueno Deckmann; Evelise de Souza Streck; Angela Malysz Sgaravatti; Mirian Bonaldi Sgarbi; Angela T S Wyse; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2010-05-01       Impact factor: 3.584

4.  [Electron microscopic and neurochemical study of Alexander's disease (author's transl)].

Authors:  R Escourolle; C de Baecque; F Gray; N Baumann; J J Hauw
Journal:  Acta Neuropathol       Date:  1979-02-15       Impact factor: 17.088

5.  Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid.

Authors:  Carolina Didonet Pederzolli; Andrea Pereira Rosa; Amanda Szekir de Oliveira; Juliana G Coelho; Débora da Luz Becker; Giovana Reche Dalazen; Tarsila Barros Moraes; Carlos S Dutra-Filho
Journal:  Mol Cell Biochem       Date:  2010-08-05       Impact factor: 3.396

6.  Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats.

Authors:  Carolina Didonet Pederzolli; Francieli Juliana Rockenbach; Fernanda Rech Zanin; Nicoli Taiana Henn; Eline Coan Romagna; Angela M Sgaravatti; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Angela de Mattos Dutra; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

7.  Canavan disease: mutations among Jewish and non-Jewish patients.

Authors:  R Kaul; G P Gao; M Aloya; K Balamurugan; A Petrosky; K Michals; R Matalon
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

8.  A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.

Authors:  Seemin Seher Ahmed; Huapeng Li; Chunyan Cao; Elif M Sikoglu; Andrew R Denninger; Qin Su; Samuel Eaton; Ana A Liso Navarro; Jun Xie; Sylvia Szucs; Hongwei Zhang; Constance Moore; Daniel A Kirschner; Thomas N Seyfried; Terence R Flotte; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

Review 9.  Canavan disease: biochemical and molecular studies.

Authors:  R Matalon; R Kaul; K Michals
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.

Authors:  Seemin Seher Ahmed; Stefan A Schattgen; Ashley E Frakes; Elif M Sikoglu; Qin Su; Jia Li; Thomas G Hampton; Andrew R Denninger; Daniel A Kirschner; Brian Kaspar; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2016-04-04       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.